NeuroBo Pharmaceuticals, Inc. Gains 29.6%

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) shot up at $1.62, a gain of 29.6%. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 04:14 PM in the 'PUBLIC OFFERING' category. From Thu, Oct 27, 2022, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Tue, Sep 13, 2022 at $63.85 with a volume of 9M+.

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.